Ge Long Hui·2026-03-31 10:05Core Viewpoint - The stock of Zhaoyan New Drug Research Center Co., Ltd. (06127.HK) experienced a significant price fluctuation, with a cumulative increase of over 20% over three consecutive trading days [1] Group 1: Stock Performance - The stock price increased significantly on March 27, March 30, and March 31, 2026, leading to a cumulative price deviation exceeding 20% [1] - This price movement is classified as an abnormal fluctuation according to the trading rules of the Shanghai Stock Exchange [1] Group 2: Company Disclosure - The company conducted a self-examination and consulted with its controlling shareholder and actual controller, confirming that there are no undisclosed significant information as of the date of the announcement [1] - Investors are advised to be cautious regarding secondary market trading risks and to make rational investment decisions [1]